64
Participants
Start Date
May 31, 2016
Primary Completion Date
September 30, 2016
Study Completion Date
December 31, 2016
Aramchol
Part A: Aramchol oral tablets at 400 mg or 600 mg single dose Part B: Aramchol oral tablets at 400 mg or 600 mg multiple dose for 10 consecutive days.
Placebo
Part A: Placebo oral tablets single dose Part B: Placebo oral tablets multiple dose for 10 consecutive days.
WCCT Global, LLC., Cypress
Lead Sponsor
WCCT Global
INDUSTRY
Alpha IRB
UNKNOWN
Analyst Research Laboratories
OTHER
Kramer Consulting, LLC
OTHER
Diamond Pharma Services Regulatory Affairs Consultancy
OTHER
Galmed Pharmaceuticals Ltd
INDUSTRY